Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 03 2023
Historique:
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 23 3 2023
Statut: epublish

Résumé

Three medications are Food and Drug Administration approved for the treatment of opioid use disorder (OUD); however, these medications are underused within prisons, which elevates the risk of relapse and overdose when persons with opioid use disorder (POUD) are released. Research is scant regarding the multilevel factors associated with POUDs' willingness to initiate medication treatment for opioid use disorder (MOUD) while in prison and their continued engagement in treatment after release. Furthermore, rural and urban populations have not been compared. The This mixed methods study employs a social ecological framework. A prospective observational longitudinal cohort study is being conducted with 450 POUDs using survey and social network data collected in prison, immediately postrelease, 6 months postrelease and 12 months postrelease to identify multilevel rural-urban variation in key outcomes. In-depth qualitative interviews are being conducted with POUDs, prison-based treatment staff and social service clinicians. To maximise rigour and reproducibility, we employ a concurrent triangulation strategy, whereby qualitative and quantitative data contribute equally to the analysis and are used for cross-validation when examining scientific aims. The GATE study was reviewed and approved by the University of Kentucky's Institutional Review Board prior to implementation. Findings will be disseminated through presentations at scientific and professional association conferences, peer-reviewed journal publications and a summary aggregate report submitted to the Kentucky Department of Corrections.

Identifiants

pubmed: 36940952
pii: bmjopen-2022-066068
doi: 10.1136/bmjopen-2022-066068
pmc: PMC10030549
doi:

Substances chimiques

Narcotic Antagonists 0
Naltrexone 5S6W795CQM
Buprenorphine 40D3SCR4GZ
Delayed-Action Preparations 0
Analgesics, Opioid 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066068

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA048876
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Subst Use Misuse. 2001 Mar;36(4):421-46
pubmed: 11346275
Annu Rev Public Health. 2015 Mar 18;36:559-74
pubmed: 25581144
J Offender Rehabil. 2009 Nov 1;48(8):725-743
pubmed: 20419069
J Opioid Manag. 2007 Mar-Apr;3(2):107-11
pubmed: 17520990
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):443-4
pubmed: 25928470
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Int J Offender Ther Comp Criminol. 2011 Jun;55(4):567-86
pubmed: 20463206
Curr Psychiatry Rep. 2013 Nov;15(11):414
pubmed: 24132733
JAMA Pediatr. 2016 Nov 1;170(11):1110-1112
pubmed: 27669331
Subst Use Misuse. 2019;54(6):873-884
pubmed: 30849266
Justice Q. 2016;33(6):1000-1028
pubmed: 27616815
Drug Alcohol Depend. 2011 May 1;115(1-2):107-12
pubmed: 21126831
MMWR Morb Mortal Wkly Rep. 2016 Jan 01;64(50-51):1378-82
pubmed: 26720857
Am J Public Health. 2014 Feb;104(2):e52-9
pubmed: 24328642
AIDS Educ Prev. 2004 Dec;16(6):499-508
pubmed: 15585427
MMWR Recomm Rep. 2017 Aug 25;66(2):1-20
pubmed: 28841201
J Urban Health. 2007 Sep;84(5):691-703
pubmed: 17682947
Am J Public Health. 2013 Jan;103(1):e44-52
pubmed: 23153148
JAMA. 2015 Oct 13;314(14):1515-7
pubmed: 26462001
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
Psychiatr Rehabil J. 2015 Mar;38(1):45-54
pubmed: 25799305
Med Care. 2016 Oct;54(10):901-6
pubmed: 27623005
J Subst Abuse Treat. 2012 Jan;42(1):95-101
pubmed: 21839606
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
Subst Use Misuse. 2014 Jun;49(7):891-901
pubmed: 24611820
J Subst Abuse Treat. 2015 Jan;48(1):77-84
pubmed: 25200740
Subst Abus. 2012;33(1):9-18
pubmed: 22263709
Subst Use Misuse. 2005;40(13-14):1983-99, 2043-8
pubmed: 16282089
AIDS Care. 2014;26(9):1071-9
pubmed: 24410251
J Rural Health. 2017 Jun;33(3):250-256
pubmed: 27467119
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331
pubmed: 27763996
Subst Abuse Rehabil. 2016 Apr 27;7:27-40
pubmed: 27217808
Addiction. 2003 May;98 Suppl 1:57-77
pubmed: 12752362
Drug Alcohol Depend. 2009 Nov 1;105(1-2):83-8
pubmed: 19625142

Auteurs

Carrie B Oser (CB)

Department of Sociology, Center on Drug & Alcohol Research, Center for Health Equity Transformation, University of Kentucky, Lexington, Kentucky, USA carrie.oser@uky.edu.

Evan Batty (E)

Department of Sociology, Center on Drug & Alcohol Research, University of Kentucky, Lexington, Kentucky, USA.

Marisa Booty (M)

Department of Sociology, Center on Drug & Alcohol Research, University of Kentucky, Lexington, Kentucky, USA.

Kate Eddens (K)

Department of Epidemiology & Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, USA.

Hannah K Knudsen (HK)

Department of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA.

Brea Perry (B)

Department of Sociology, Irsay Family Research Institute, Indiana University, Bloomington, Indiana, USA.

Maria Rockett (M)

Department of Sociology, Center on Drug & Alcohol Research, Center for Health Equity Transformation, University of Kentucky, Lexington, Kentucky, USA.

Michele Staton (M)

Department of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH